CRCM »

Atrium Therapeutics shares owned by CRCM

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by CRCM from 13F filings

Historical chart of CRCM investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by CRCM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by CRCM

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.8M 583k 13.45

More positions owned by CRCM

Ishares Gold Trust Etf Ishares New (IAU)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Atrium Therapeutics (RNA)
Janone (AIFC)
Bitgo Holdings Inc-cl A Com Shs Cl A (BTGO)
Ishares 0-3 Month Treasury B SHS (SGOV)
Vizsla Silver Corp Com New (VZLA)
Burning Rock Biotech Ltd- Sponsored Ads (BNR)
Procap Acquisition Corp - A Shs Cl A (PCAP)
Perceptive Capital Solutions Cl A Ord Shs (PCSC)
Plby Group Ord (PLBY)
First Tracks Biotherapeutics Ord Shs (TRAX)

View all positions for CRCM

Top funds holding Atrium Therapeutics

T. Rowe Price Associates
BlackRock
Susquehanna International
Vanguard Capital Management
CRCM
TIG Advisors
Sessa Capital IM
Geode Capital Management
Farallon Capital Management
Two Sigma Investments
Goldman Sachs Group
683 Capital Management
Bellevue Group
State Street Corporation
Cantor Fitzgerald, L. P.

View all funds holding Atrium Therapeutics